Stay updated with breaking news from Rhinitis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
People with allergic conditions such as hay fever, rhinitis, and atopic eczema, may have a lower risk of COVID-19 infection, especially if they also have asthma, finds a large, population-based study of UK adults, published online in the respiratory journal Thorax.
In a recent interview, Microsoft founder Bill Gates, a longtime advocate for pandemic preparedness, gave concrete suggestions for steps we should be taking.
Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company, has received marketing approval for its fixed-dose combination nasal
Photo Credit: IANS IANSLive Chennai, May 3 (IANS) Pharma major Glenmark Pharmaceuticals Limited on Monday announced the launch of Ryaltris-AZ nasal spray for the treatment of moderate to severe allergic rhinitis, in India. To get full access of the story, click here to subscribe to IANS News Service © 2021 IANS India Private Limited. All Rights Reserved. The reproduction of the story/photograph in any form will be liable for legal action. For news, views and gossips, follow IANS at Twitter. Update: 03-May-2021
Chennai: Pharma major Glenmark Pharmaceuticals Limited on Monday announced the launch of Ryaltris-AZ nasal spray for the treatment